Remove 2007 Remove Food and Drug Administration Remove Leads
article thumbnail

Developing a holistic approach to cardio, metabolic and renal disease

European Pharmaceutical Review

According to the World Health Organization (WHO), CVDs are the leading cause of death worldwide accounting for 32 percent of global deaths in 2019 (approximately 17.9 This theory has been supported by the clinical results of drugs such as empagliflozin, the SGLT2 inhibitor, across several of these conditions. 2021 [cited 8 June 2022].

article thumbnail

THEPM360TRAILBLAZER AWARD WINNER – Lifetime Achievement Award – Adam Schechter, CEO and Chairman, Labcorp

PM360

Prior to that, he was named Lead Independent Director in 2019 after serving as a director of the company since 2013. Prior to becoming President of Global Human Health, he served as President of Merck’s global pharmaceutical business from 2007 to 2010. Food and Drug Administration (FDA) approval.

Ethics 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Future for Biotesting

Pharmaceutical Technology

Firstly, there is a comprehensive toxicological service for human and veterinary pharmaceuticals and biopharmaceuticals, food additives, chemicals and agrochemicals. NC: A few projects focusing on influenza, which Biotest was involved with, concluded in 2007. It will most probably lead to a new anti-flu vaccine.

article thumbnail

Innovations & Challenges in Brain Health

PM360

They are difficult to diagnose early in a disease, the regulatory endpoints are often unprecedented and challenging, and many drugs struggle to get into the brain. The downside is that it also keeps most potential drug treatments from reaching the brain. Not surprisingly, several companies have been in and out of brain health diseases.